{
  "meta": {
    "title": "Liver",
    "url": "https://brainandscalpel.vercel.app/liver-8d7ae95d.html",
    "scrapedAt": "2025-11-29T18:41:09.332Z"
  },
  "questions": [
    {
      "id": 11782,
      "choices": [
        {
          "id": 47094,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Portal pyemia</span></span></span></p>"
        },
        {
          "id": 47095,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Empyema of Gall Bladder</span></span></span></p>"
        },
        {
          "id": 47096,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ascending cholangitis</span></span></span></p>"
        },
        {
          "id": 47097,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Entameba&nbsp;</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 50-year-old, chronic alcoholic male with history of high-grade fever with chills expired at home. His postmortem examination showed the following finding on liver sections. What is the most common cause of the below condition?</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/29/picture17.jpg\" style=\"height:243px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q5792302",
      "question_audio": null,
      "question_video": null,
      "map_id": 36497,
      "difficulty_level": "difficult",
      "subjects_id": [
        12
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Ascending cholangitis</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The above pathology is <strong>pyogenic liver abscess</strong>. <strong>MC cause is ascending cholangitis secondary to biliary obstruction like CBD stones.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ascending cholangitis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, an <strong>infection of the bile ducts</strong>, is indeed a <strong>common cause of pyogenic liver abscesses</strong>. <strong>Bacteria</strong> from the <strong>intestinal tract ascend the bile ducts into the liver</strong>, leading to <strong>abscess formation</strong>. This usually occurs in setting of CBD stones.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Portal Pyemia. </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Portal pyemia refers to <strong>infection in the portal vein system</strong>, which can result in <strong>multiple liver abscesses due to the spread of bacteria from the gastrointestinal tract</strong>. However, it is not the most common cause of pyogenic liver abscesses.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Empyema of Gall Bladder. </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Empyema of the gallbladder is the <strong>accumulation of pus within the gallbladder</strong>, which can lead to <strong>liver abscesses if the infection spreads</strong>, but it is not as common as biliary tract infections leading to cholangitis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Entameba. </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Entameba can <strong>lead to amebic liver abscess</strong>. However, the given condition of high grade fever with chills, and yellow colored purulent lesions are not seen. Amebic liver abscess shows anchovy sauce pus.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ascending cholangitis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, due to <strong>infection ascending the biliary tree</strong>, is a <strong>common cause of pyogenic liver abscesses</strong> and is typically associated with <strong>polymicrobial infections involving organisms such as Klebsiella, E. coli, and Streptococcus milleri group</strong>. Diagnosis and management involve imaging, aspiration, and appropriate antibiotic therapy.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Biliary tract pathology is the most common source (35%), followed by portal spread from the gastrointestinal tract, including diverticulitis and appendicitis (20%). </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other unusual etiologies include contiguous spread from sub phrenic or intra-abdominal collections, bacteremia secondary to trauma or infected cysts and necrotic tumors following chemotherapy. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Worldwide, bacteria remain the most common; although infection is usually polymicrobial Klebsiella, Escherichia coli and the Streptococcus milleri group are the usual organisms identified. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">There is an increased incidence in the elderly, those with diabetes and the immunosuppressed and presentation is usually with anorexia, fever, and malaise and right upper quadrant discomfort</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The diagnosis is suggested by the finding of a multiloculated cystic mass on ultrasonography or CT scan and is confirmed by aspiration.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Treatment of liver abscesses initially requires identification of the source, if possible, aspiration of the lesion for microbiology and culture (repeated aspirations may be required) and treatment with appropriate antibiotics</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A combination of two or more antibiotics is recommended. Metronidazole and clindamycin provide wide anaerobic coverage and excellent penetration into the abscess cavity. Third-generation cephalosporins and aminoglycosides are very effective against most Gram-negative organisms.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Bailey 28<sup>th</sup> Ed. Pg 1209 </span></span></strong></p>",
      "correct_choice_id": 47096,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11770,
      "choices": [
        {
          "id": 47046,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hepatic adenoma</span></span></span></p>"
        },
        {
          "id": 47047,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hemangioma</span></span></span></p>"
        },
        {
          "id": 47048,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metastasis</span></span></span></p>"
        },
        {
          "id": 47049,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hepatoma</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 58-year-old male with history of chronic alcohol consumption on routine check-up was found to have hepatomegaly. His LFT was essentially normal, Serum AFP was 490 ng//ml. CECT showed rapidly enhancing mass in the setting of nodularity. What is the likely diagnosis?</span></span></span></p>",
      "unique_key": "Q4203123",
      "question_audio": null,
      "question_video": null,
      "map_id": 36510,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Hepatoma</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The clinical scenario is suggestive of <strong>hepatoma</strong> in a patient with <strong>cirrhosis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hepatomas show CECT triple phase/ MRI liver</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">- <strong>early enhancement in arterial phase</strong>, <strong>washout in venous.</strong> </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hepatoma</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, or <strong>hepatocellular carcinoma</strong> (HCC), is a <strong>primary malignant tumor of the liver</strong> commonly associated with <strong>cirrhosis and chronic alcohol use</strong>. The classic imaging features of <strong>HCC on contrast-enhanced computed tomography</strong> (CECT) or <strong>MRI</strong> include <strong>early arterial enhancement</strong> followed by <strong>washout in the venous phase</strong>, which aligns with the findings described in the scenario. This, combined with the elevated AFP level, strongly suggests HCC as the diagnosis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Hepatic Adenoma. </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hepatic adenoma is a <strong>benign liver tumor</strong> often <strong>associated with oral contraceptive use and anabolic steroid use</strong>, less commonly linked to alcohol. They typically do not show rapid enhancement and washout on imaging, making this less likely in the context of cirrhosis and elevated AFP.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Hemangioma. </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Liver hemangiomas are the <strong>most common benign liver tumors and are typically asymptomatic.</strong> On imaging, they show a characteristic pattern of peripheral nodular enhancement with centripetal filling, not early arterial enhancement and venous washout.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Metastasis. </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metastatic lesions to the <strong>liver can present with various imaging features</strong>, but the <strong>combination of cirrhosis</strong>, <strong>elevated AFP</strong>, and the described enhancement pattern is more suggestive of primary liver cancer than metastasis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a patient with <strong>cirrhosis and an elevated AFP</strong> who presents with a <strong>liver mass showing early arterial enhancement</strong> and <strong>venous phase washout on imaging</strong>, <strong>hepatocellular carcinoma</strong> (HCC) is the most likely diagnosis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic hepatitis B virus (HBV) infection accounts for &gt;50% of cases worldwide and HBV vaccination programmes reduce the incidence in high-risk areas. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hepatitis C virus (HCV) increases the risk of HCC 17-fold by promoting end-stage liver disease. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lifetime alcohol exposure remains an intractable risk factor and correlates with the incidence of HCC. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Obesity and diabetes mellitus are additional independent risk factors</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Imaging is a critical part of the preoperative assessment of HCC and accurate tumour staging and anatomical assessment is essential to determine technical and oncological resectability and exclude metastatic disease. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Triple-phase CT chest/ abdomen/pelvis and MRI of the liver is the standard of care,</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The early arterial phase following intravenous contrast detects small hepatocellular carcinomas (HCCs) owing to their predominantly arterial blood supply. The venous phase demonstrates branches of the intrahepatic portal vein and the hepatic veins. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inflammatory liver lesions often exhibit rim enhancement with intravenous contrast, whereas haemangiomas characteristically show late venous enhancement.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Bailey 28<sup>th</sup> Ed. Pg 1196, 1215 </span></span></strong></p>",
      "correct_choice_id": 47049,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11766,
      "choices": [
        {
          "id": 47030,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A</span></span></span></p>"
        },
        {
          "id": 47031,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B</span></span></span></p>"
        },
        {
          "id": 47032,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C</span></span></span></p>"
        },
        {
          "id": 47033,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the Child-Pugh-Turcotte stage of a patient with Bilirubin 2.5mg%, Albumin 3g%, INR 2, mild ascites and no encephalopathy?</span></span></p>",
      "unique_key": "Q7773303",
      "question_audio": null,
      "question_video": null,
      "map_id": 36508,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) B</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">Bilirubin 2.5 mg%= 2 points</p>\r\n\r\n<p style=\"text-align:justify\">Albumin 3g%= 2 points</p>\r\n\r\n<p style=\"text-align:justify\">INR 2 = 2 points</p>\r\n\r\n<p style=\"text-align:justify\">Mild Ascites= 2 points</p>\r\n\r\n<p style=\"text-align:justify\">No encephalopathy= 1 point</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Total score in this patient: 9&rarr; Child B</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/29/screenshot-2024-03-28-181509.jpg\" style=\"height:407px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Bailey 28<sup>th</sup> Ed. PG 1196 </span></strong></span></span></p>",
      "correct_choice_id": 47031,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11752,
      "choices": [
        {
          "id": 46974,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cantlie&rsquo;s line passes through the GB fossa</span></span></span></p>"
        },
        {
          "id": 46975,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cantlie&#39;s line divides the liver functionally into two lobes</span></span></span></p>"
        },
        {
          "id": 46976,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The left lobe of the liver has 4 segments and the right lobe has 3</span></span></span></p>"
        },
        {
          "id": 46977,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The caudate lobe is drained by the middle hepatic vein</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Choose the incorrect statement regarding liver anatomy?</span></span></span></p>",
      "unique_key": "Q5055961",
      "question_audio": null,
      "question_video": null,
      "map_id": 36501,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) The left lobe of the liver has 4 segments and the right lobe has 3 segments.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This statement is <strong>incorrect</strong>. According to <strong>Couinaud&rsquo;s classification,</strong> the <strong>liver is divided into eight segments</strong>. The <strong>left lobe comprises segments II, III, and IV</strong>, while the <strong>right lobe consists of segments V, VI, VII, and VIII</strong>, making <strong>four segments in the right lobe and three in the left lobe</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>liver is sub-divided into 8 segments</strong> called the <strong>Couinaud&rsquo;s segments</strong>. The <strong>liver&rsquo;s left lobe has 3 segments</strong>, and the <strong>right lobe has 4 segments</strong>, while caudate lobe (posterior) is numbered as segment 1 and considered separately.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">&nbsp;</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/29/picture11.jpg\" style=\"height:341px; width:400px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A and B: Cantlie&rsquo;s line passes through the GB fossa. Cantlie&rsquo;s line divides the liver functionally into two lobes. </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cantlie&rsquo;s line</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, or the <strong>principal plane</strong>, runs from the <strong>gallbladder fossa to the inferior vena cava</strong> (IVC) and is used to divide the liver into right and left lobes functionally. This statement is correct.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: The caudate lobe is drained by the middle hepatic vein</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. This statement is generally considered <strong>true</strong>. The caudate lobe (segment I) is unique in that it receives blood flow from both the right- and left-sided portal venous branches and is drained by multiple small hepatic veins, including branches of the middle hepatic vein.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>right lobe of the liver has four segments</strong>, while the <strong>left lobe has three</strong>, with <strong>Cantlie&#39;s line dividing the liver into these two functional lobes</strong>, and the <strong>caudate lobe is drained by the middle hepatic vein</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The liver is composed of eight segments, each supplied by terminal branches of the portal vein (80% of the blood flow) and hepatic artery (20%) and drained by bile ducts and hepatic veins.&nbsp; <strong>The Cantlie&rsquo;s line is an imaginary line that divides the liver functionally into 2 lobes. It represents the GB fossa, the IVC and the middle hepatic vein.</strong> </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Venous drainage: right hepatic veins drain the right lobe of liver, the middle hepatic vein drains the caudate lobe and the left hepatic veins drain the left lobe.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Bailey 28<sup>th</sup> Ed. Pg 1192</span></span></strong></p>",
      "correct_choice_id": 46976,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11754,
      "choices": [
        {
          "id": 46982,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Independent origin of the right and left hepatic arteries from the celiac axis</span></span></span></p>"
        },
        {
          "id": 46983,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Replaced left hepatic artery arising from superior mesenteric artery</span></span></span></p>"
        },
        {
          "id": 46984,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Replaced right hepatic artery arising from the superior mesenteric artery</span></span></span></p>"
        },
        {
          "id": 46985,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Replaced right hepatic artery arising from left gastric artery</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the most common vascular anomaly of the liver?</span></span></span></p>",
      "unique_key": "Q8921045",
      "question_audio": null,
      "question_video": null,
      "map_id": 36502,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Replaced right hepatic artery arising from superior mesenteric artery</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The most <strong>common anomaly of the hepatic artery</strong> is <strong>replaced right hepatic artery</strong> arising from the <strong>superior mesenteric artery.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Independent origin of the right and left hepatic arteries from the celiac axis. </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Normally, the c<strong>ommon hepatic artery</strong> arises from the <strong>celiac trunk</strong> and <strong>gives rise to the right and left hepatic arteries</strong>. Independent origin of both hepatic arteries directly from the celiac axis is less common.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Replaced left hepatic artery arising from superior mesenteric artery. </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A <strong>replaced left hepatic artery</strong> typically <strong>arises from the left gastric artery</strong>, not the superior mesenteric artery. This anomaly is less common compared to the right hepatic artery anomalies.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Replaced right hepatic artery arising from left gastric artery. </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>right hepatic artery</strong> typically <strong>does not arise from the left gastric artery</strong>. When it is &quot;replaced,&quot; it more commonly originates from the superior mesenteric artery.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>most common vascular anomaly of the liver</strong> is the <strong>presence of a replaced right hepatic artery</strong> arising from the <strong>superior mesenteric artery,</strong> which is an important consideration in hepatic surgeries and liver transplantation due to its implications on surgical planning and postoperative outcomes.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/29/picture12.jpg\" style=\"height:195px; width:350px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>arterial blood supply</strong> is <strong>variable in origin</strong> and <strong>course</strong> but in <strong>most individuals is derived from the coeliac trunk</strong>, which usually <strong>divides into left gastric</strong>, common <strong>hepatic and splenic arteries.</strong> </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">After supplying the gastroduodenal artery, the hepatic artery branches at a variable level to produce the right and left hepatic arteries, the larger right branch supplying the right lobe. </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:48px; text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/29/picture13.jpg\" style=\"height:240px; width:350px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Normal arterial anatomy of liver</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The right lobe may be partly or completely supplied by a right hepatic artery arising directly from the superior mesenteric artery running to the liver on the posterior wall of the bile duct after passing behind the uncinate process and head of the pancreas. </span></strong></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Similarly, the left lobe artery may be augmented or replaced by a branch of the left gastric artery running in the lesser omentum from the lesser curve of the stomach.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Surgical significance: Replaced right hepatic artery is a beneficial variant in living donors of right liver. The common postoperative complication in liver transplantation is hepatic artery thrombosis because of shorter and thinner hepatic artery graft but replaced right hepatic artery in liver transplant donor provides a longer and larger graft thus reducing chances of thrombosis.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">On the other hand, replaced right artery in the recipient increases the risk of hepatic artery complications after transplantation due to the small caliber of the common hepatic artery.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Bailey 28<sup>th</sup> Ed. Pg 1192, 1210. Sabiston 21<sup>st</sup> Ed. Pg 1432-33</span></strong></span></span></p>",
      "correct_choice_id": 46984,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11763,
      "choices": [
        {
          "id": 47018,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Organism typically affects the colon</span></span></span></p>"
        },
        {
          "id": 47019,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The life cycle is partly in sheep and partly in man</span></span></span></p>"
        },
        {
          "id": 47020,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The treatment of choice is metronidazole with chloroquine and diloxanide furoate</span></span></span></p>"
        },
        {
          "id": 47021,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The aspirate shows &ldquo;sterile pus&rdquo; on microscopy</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old male had visited India a couple of months back. He had a history of bloody diarrhea for a few days on returning, which subsided on its own. He now presents with right upper abdominal pain, low grade fever, and weight loss. On examination, the patient shows pallor and tender hepatomegaly. Following image is obtained. What is incorrect about this disease?</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/29/picture15.jpg\" style=\"height:200px; width:300px\" /></span></span></p>",
      "unique_key": "Q8319445",
      "question_audio": null,
      "question_video": null,
      "map_id": 36506,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) The life cycle is partly in sheep and partly in man.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The above clinical scenario with the CT image is suggestive of <strong>amebic liver abscess</strong>. It&#39;s caused by the <strong>parasite Entamoeba Histolytica</strong>. Its entire <strong>life cycle is entirely in man</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Organism typically affects the colon. </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is <strong>correct</strong>. Entamoeba histolytica primarily infects the colon and can cause amebic dysentery, flask shaped ulcers in cecum or sigmoid colon</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: The treatment of choice is metronidazole with chloroquine and diloxanide furoate. </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is <strong>correct.</strong> Metronidazole is the drug of choice for invasive amoebiasis, and diloxanide furoate is used as a luminal agent to eliminate intraluminal cysts. Chloroquine may be used adjunctively for the treatment of amebic liver abscesses, particularly when metronidazole alone is insufficient.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: The aspirate shows &ldquo;sterile pus&rdquo; on microscopy. </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is <strong>correct</strong>. Aspirates from an amebic liver abscess typically do not show bacteria when cultured, hence the term &quot;sterile pus.&quot; The aspirate is often described as looking like &quot;anchovy sauce&quot; due to the presence of necrotic liver tissue and blood.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Entamoeba histolytica</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is the <strong>causative agent of amebic liver abscess</strong>, with a <strong>life cycle that occurs exclusively in humans, not sheep</strong>. The treatment includes <strong>metronidazole</strong>, often combined with other agents like <strong>chloroquine and diloxanide furoate</strong>, and the condition is <strong>characterized by &quot;sterile pus&quot; in the liver abscess aspirate.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The organism enters the gut through food or water contaminated with the cyst. In the small bowel, the cysts hatch and a large number of trophozoites are released and<strong> carried to the colon, where flask-shaped ulcers form in the submucosa.</strong> The trophozoites multiply, ultimately forming cysts, which either enter the portal circulation or are passed in the faeces as an infective form that infects other humans as a result of insanitary conditions.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Having entered the portal circulation, the trophozoites are filtered and trapped in the interlobular veins of the liver. They multiply in the portal triads, causing focal infarction of hepatocytes and liquefactive necrosis as a result of proteolytic enzymes produced by the trophozoites. The areas of necrosis eventually coalesce to form the abscess cavity. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The typical patient with an amoebic liver abscess is a young adult male with a history of insidious onset of non-specific symptoms, such as abdominal pain, anorexia, fever, night sweats, malaise, cough and weight loss. These symptoms gradually progress to more specific symptoms of pain in the right upper abdomen and right shoulder tip, hiccoughs and a non-productive cough. A past history of bloody diarrhoea or travel to an endemic area raises the index of suspicion.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The abscess cavity contains chocolate colored, odorless, &lsquo;anchovy sauce&rsquo;-like fluid that is a mixture of necrotic liver tissue and blood.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">On ultrasonography, an abscess cavity in the liver is seen as a hypoechoic or anechoic lesion with ill-defined borders; internal echoes suggest necrotic material or debris. The investigation is very accurate and is used for aspiration, both diagnostic and therapeutic. When there is doubt about the diagnosis, a computed tomography (CT) scan may be helpful. <strong>Diagnostic aspiration is of limited value except for establishing the typical colour of the aspirate, which is sterile and odorless unless it is secondarily infected</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Medical treatment is very effective and should be the first choice in the elective situation, with surgery being reserved for complications.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span></span><br />\r\n\t&nbsp;</li>\r\n</ul>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Bailey 28<sup>th</sup> Ed. Pg 66-68</span></span></strong></p>",
      "correct_choice_id": 47019,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11764,
      "choices": [
        {
          "id": 47022,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Formalin</span></span></span></p>"
        },
        {
          "id": 47023,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cetrimide</span></span></span></p>"
        },
        {
          "id": 47024,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypertonic saline</span></span></span></p>"
        },
        {
          "id": 47025,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Polyvinylpyrrolidone iodine</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A sheep farmer presented to the hospital with a history of pain in the upper part of the abdomen. After a detailed clinical, laboratory, and radiological investigation, a 5 cm single hydatid cyst was found in the right lobe of the liver. The surgeon decides to perform a percutaneous aspiration, injection, and respiration (PAIR) of the cyst. All of the following can be used as scolicidal agents in this procedure except:</span></span></span></p>",
      "unique_key": "Q8503325",
      "question_audio": null,
      "question_video": null,
      "map_id": 36507,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Formalin</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Formalin</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is <strong>not used as a scolicidal agent</strong> in the <strong>PAIR procedure because it can cause sclerosing cholangitis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Cetrimide. </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cetrimide is an <strong>antiseptic agent</strong> that can be <strong>used as a scolicidal agent during the PAIR procedure</strong> to <strong>kill the protoscolices of the Echinococcus parasite</strong> and prevent secondary hydatidosis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Hypertonic Saline. </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypertonic saline solution is commonly <strong>used as a scolicidal agent due to its osmotic effect</strong>, which can <strong>effectively kill the protoscolices during the PAIR procedure</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Polyvinylpyrrolidone Iodine. </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Polyvinylpyrrolidone iodine, <strong>commonly known as povidone-iodine</strong>, is an <strong>iodophor solution with antiseptic properties</strong> and can be used as a scolicidal agent during the PAIR procedure.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When <strong>performing the PAIR procedure for a hydatid cyst</strong>, <strong>scolicidal agents</strong> such as <strong>hypertonic saline, cetrimide, and povidone-iodine are used</strong> to prevent <strong>dissemination of the parasite,</strong> whereas <strong>formalin is contraindicated due to the risk of causing sclerosing cholangitis</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Formalin is not used as a scolicidal agent</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> since it causes <strong>sclerosing cholangitis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Scolicidal agents (used to avoid dissemination of parasite during surgery)</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypertonic saline (15-20%)</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cetrimide</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alcohol (75-95%)</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Povidone-iodine (5-10%)</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Bailey 28<sup>th</sup> Ed. Pg 76</span></strong></span></span></p>",
      "correct_choice_id": 47022,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11771,
      "choices": [
        {
          "id": 47050,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Performance status</span></span></span></p>"
        },
        {
          "id": 47051,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Portal Vein invasion</span></span></span></p>"
        },
        {
          "id": 47052,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Number of tumors</span></span></span></p>"
        },
        {
          "id": 47053,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">AFP (alpha feto-protein)</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of these are components of Barcelona Clinic for Liver Cancer (BCLC) staging except:</span></span></span></p>",
      "unique_key": "Q2334699",
      "question_audio": null,
      "question_video": null,
      "map_id": 36511,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) AFP </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(alpha feto-protein)</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alpha-fetoprotein</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (AFP) is a <strong>tumor marker often elevated in HCC</strong>; however, <strong>it is not a component of the BCLC staging system</strong>, which <strong>focuses on tumor burden</strong>, <strong>liver function</strong> (Child-Pugh score), and <strong>physical status</strong> rather than <strong>serum tumor markers.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>Barcelona Clinic Liver Cancer</strong> (BCLC) <strong>staging system is a widely used framework for stratifying patients with hepatocellular carcinoma</strong> (HCC) based on various prognostic factors. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Performance Status. </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>Eastern Cooperative Oncology Group</strong> (ECOG) <strong>performance status</strong> is a <strong>component of the BCLC staging system</strong>, assessing how the disease affects the patient&#39;s daily living abilities.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Portal Vein Invasion. </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Portal vein (PV) invasion or <strong>thrombosis is a critical factor in the BCLC staging system</strong>, indicating more advanced disease and influencing treatment decisions.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Number of Tumors. </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The number of tumors, <strong>their size, and the presence of extrahepatic spread are part of the TNM</strong> (Tumor, Node, Metastasis) classification, which is incorporated into the BCLC staging.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the <strong>BCLC staging system for hepatocellular carcinoma,</strong> important components include the <strong>TNM staging, portal vein invasion, Child-Pugh score, and ECOG performance status</strong>, while AFP is not included in the staging criteria.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The Barcelona clinic includes</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">TNM staging (size, no. of tumors, metastasis) </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PV invasion</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Child Pugh score</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ECOG: performance status </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>Cancer of the Liver Italian Program</strong> (CLIP) <strong>score</strong> is used for <strong>prognostic staging of HCC</strong> and includes <strong>variables such as tumor morphology</strong>,<strong> AFP levels</strong>, <strong>Child-Pugh stage</strong>, and portal vein thrombosis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Bailey 28<sup>th</sup> Ed. Pg 1215</span></span></strong></p>",
      "correct_choice_id": 47053,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11773,
      "choices": [
        {
          "id": 47058,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Wide excision</span></span></span></p>"
        },
        {
          "id": 47059,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Liver Transplant</span></span></span></p>"
        },
        {
          "id": 47060,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">TACE (trans-arterial chemoembolization)</span></span></span></p>"
        },
        {
          "id": 47061,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sorafenib&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">According to BCLC, patient with multi-lobular liver cancer with good performance status and Child&rsquo;s A disease should be managed by:</span></span></span></p>",
      "unique_key": "Q4865011",
      "question_audio": null,
      "question_video": null,
      "map_id": 36512,
      "difficulty_level": "difficult",
      "subjects_id": [
        12
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. TACE (trans-arterial chemoembolization)</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">TACE</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is the <strong>treatment of choice for asymptomatic patients with multinodular HCC</strong> (stage B) who <strong>do not have vascular invasion</strong> or <strong>extrahepatic spread</strong> and have <strong>preserved liver function</strong> (Child-Pugh A or B).</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Given a patient with <strong>multi-lobular liver cancer</strong>, <strong>good performance status</strong>, and <strong>Child&rsquo;s A disease</strong>, according to <strong>BCLC</strong>, the <strong>appropriate management would be TACE</strong>, <strong>assuming the patient falls into stage B of HCC</strong>, where the disease is more advanced than early-stage but has not yet reached the criteria for systemic therapy or best supportive care.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Wide excision. </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Wide excision, or <strong>surgical resection</strong>, is typically recommended for <strong>patients with early-stage HCC</strong> (stage 0&ndash;A), who have a <strong>single tumor and good liver function</strong>, without evidence of vascular invasion or extrahepatic spread.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Liver Transplant. </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Liver transplantation is <strong>considered for patients with early-stage HCC</strong> (stage 0&ndash;A) who <strong>meet specific criteria</strong>, such as the <strong>Milan criteria</strong> (single HCC &le; 5 cm or up to 3 nodules each &le; 3 cm), and no evidence of extrahepatic disease or vascular invasion.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Sorafenib. </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sorafenib is an <strong>oral tyrosine kinase inhibitor</strong> used for <strong>patients with advanced HCC</strong> (stage C) that has <strong>spread or cannot be treated with surgery or TACE</strong>. This is suitable for patients with vascular invasion or extrahepatic disease and good performance status.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the <strong>BCLC staging system for HCC</strong>, patients with <strong>multinodular, non-early-stage tumors</strong> and <strong>preserved liver function</strong> (Child&rsquo;s A) are typically <strong>managed with trans-arterial chemoembolization</strong> (TACE), reflecting a balance between therapeutic intervention and the patient&rsquo;s liver function reserve.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>Barcelona Clinic Liver Group staging system</strong> for the <strong>management of hepatocellular carcinoma</strong> (HCC). </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Patients with asymptomatic early tumors (stage 0&ndash;A) are candidates for curative therapies (resection, transplantation or local ablation). </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Asymptomatic patients with <strong>multinodular HCC (stage B)</strong> are suitable for chemoembolization (TACE)</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Patients with advanced symptomatic tumors and/or an invasive tumoral pattern (stage C) are candidates for Sorafenib. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">End-stage disease (stage D) includes patients with grim prognosis who should be treated by best supportive care</span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Bailey 28<sup>th</sup> Ed. Pg 1215</span></span></strong></p>",
      "correct_choice_id": 47060,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11783,
      "choices": [
        {
          "id": 47098,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Astler Coller</span></span></span></p>"
        },
        {
          "id": 47099,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Barcelona clinic</span></span></span></p>"
        },
        {
          "id": 47100,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">OKUDA</span></span></span></p>"
        },
        {
          "id": 47101,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CLIP&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of these are staging systems used for liver cancer except:</span></span></span></p>",
      "unique_key": "Q7207523",
      "question_audio": null,
      "question_video": null,
      "map_id": 36498,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans.&nbsp; A) Astler coller</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>Astler-Coller classification</strong> is indeed <strong>not a staging system for liver cancer</strong>. It is a <strong>modification of the Dukes classification</strong> and is used <strong>specifically for staging colorectal cancer</strong>, not liver cancer.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Astler Coller</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is a <strong>modification of Dukes classification</strong> for <strong>staging colorectal carcinomas</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Barcelona Clinic. </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>Barcelona Clinic Liver Cancer</strong> (BCLC) <strong>staging system</strong> is widely <strong>used for staging liver cancer</strong>, particularly hepatocellular carcinoma (HCC). It incorporates tumor characteristics, liver function, performance status, and cancer-related symptoms.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: OKUDA. </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The Okuda staging system is an <strong>older staging system for liver cancer that includes tumor size</strong>, <strong>serum albumin</strong>, <strong>bilirubin levels</strong>, and the presence of ascites to determine the stage of liver cancer.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: CLIP. </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>Cancer of the Liver Italian Program</strong> (CLIP) <strong>score</strong> is used for <strong>prognostic staging of HCC</strong> and includes <strong>variables such as tumor morphology</strong>, <strong>AFP levels</strong>, <strong>Child-Pugh stage</strong>, and <strong>portal vein thrombosis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>Astler-Coller classification</strong> is a <strong>staging system for colorectal carcinomas</strong>, <strong>not liver cancer</strong>, while the <strong>Barcelona clinic</strong>, <strong>OKUDA</strong>, and <strong>CLIP are staging systems used for liver cancer</strong>, specifically hepatocellular carcinoma.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Bailey 28<sup>th</sup> Ed. Pg 1407 </span></span></strong></p>",
      "correct_choice_id": 47098,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11786,
      "choices": [
        {
          "id": 47110,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thrombocytopenia </span></span></span></p>"
        },
        {
          "id": 47111,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hepatic adenoma</span></span></span></p>"
        },
        {
          "id": 47112,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Coagulopathy</span></span></span></p>"
        },
        {
          "id": 47113,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hemolysis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is not a component of Kassabach Meritt syndrome?</span></span></span></p>",
      "unique_key": "Q8613982",
      "question_audio": null,
      "question_video": null,
      "map_id": 36499,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Hepatic adenoma</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hepatic adenoma</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is a type of <strong>liver tumor</strong> and is <strong>not associated with KMS</strong>. The <strong>syndrome is typically related to vascular tumors</strong> like <strong>hemangiomas</strong>, <strong>not adenomas</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kasabach-Merritt syndrome</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is seen in <strong>giant liver hemangiomas</strong>, not adenoma.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>components of Kasabach-Merritt Syndrome</strong> (KMS), a <strong>rare vascular disorder,</strong> include the following:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Thrombocytopenia. </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thrombocytopenia, or <strong>low platelet count</strong>, is a key feature of KMS and occurs as platelets are consumed within the vascular lesion.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Coagulopathy. </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Consumptive coagulopathy</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, where <strong>clotting factors are consumed at a rate faster than they can be produced</strong>, is another hallmark of KMS.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Hemolysis. </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Intravascular hemolysis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> can <strong>occur in KMS due to the mechanical destruction of red blood cells</strong> as they pass through the vascular tumor.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kasabach-Merritt Syndrome</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is characterized by the <strong>triad of thrombocytopenia, consumptive coagulopathy, and hemolysis</strong>, typically <strong>associated with vascular lesions such as giant hemangiomas</strong>, not hepatic adenomas.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hemangioma of liver:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MC benign liver SOL</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Asymptomatic/ incidental</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If &gt; 5cm</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: May lead to Kassabach Merrit Syndrome </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hemangioma causes hemolysis + Thrombocytopenia + consumptive Coagulopathy.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong>CT Abdomen</strong>: delayed enhancement</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong>Treatment</strong>:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Excision if symptomatic</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Bailey 28<sup>th</sup> Ed. Pg 1213</span></strong></span></span></p>",
      "correct_choice_id": 47111,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11777,
      "choices": [
        {
          "id": 47074,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gall bladder adenocarcinoma</span></span></span></p>"
        },
        {
          "id": 47075,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pancreatic adenocarcinoma</span></span></span></p>"
        },
        {
          "id": 47076,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stomach adenocarcinoma</span></span></span></p>"
        },
        {
          "id": 47077,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Colo-rectal adenocarcinoma</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In patients with secondary metastasis to liver, most common primary site is?</span></span></span></p>",
      "unique_key": "Q7284465",
      "question_audio": null,
      "question_video": null,
      "map_id": 36495,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Colo-rectal adenocarcinoma</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Colorectal cancer</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is indeed the <strong>most common primary site for liver metastases</strong>. The <strong>liver</strong> is a <strong>frequent site of spread</strong> due to the <strong>direct blood flow from the colon and rectum via the portal vein</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Gall bladder adenocarcinoma. </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While gall bladder cancers can <strong>metastasize to the liver</strong> due to the <strong>proximity of the gallbladder to the liver</strong>, they are <strong>not the most common source of liver metastases.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Pancreatic adenocarcinoma. </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pancreatic cancer can <strong>metastasize to the liver</strong>, but like gall bladder adenocarcinoma, it is <strong>not the most common primary source of liver metastases.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Stomach adenocarcinoma. </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stomach or <strong>gastric cancers</strong> can <strong>spread to the liver</strong>, but colorectal cancer is more commonly associated with liver metastases.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>most common primary cancer to metastasize to the liver is colorectal adenocarcinoma,</strong> with a significant proportion of <strong>patients developing synchronous or metachronous liver metastases</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Worldwide colorectal cancer</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (CRC) is the <strong>third most common solid organ malignancy</strong> and the <strong>fourth most common cause of cancer-related deaths</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Up to 70% of patients with CRC develop synchronous (15&ndash;25%) or metachronous (20&ndash;45%) liver metastases.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Bailey 28<sup>th</sup> Ed. Pg 1216</span></span></strong></p>",
      "correct_choice_id": 47077,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11756,
      "choices": [
        {
          "id": 46990,
          "text": "<p><span style=\"font-size:12pt;\">Man is the dead end host</span></p>"
        },
        {
          "id": 46991,
          "text": "<p><span style=\"font-size:12pt;\">FNAC is contraindicated</span></p>"
        },
        {
          "id": 46992,
          "text": "<p><span style=\"font-size:12pt;\">PAIR is the treatment of choice in cysto-biliary communication</span></p>"
        },
        {
          "id": 46993,
          "text": "<p><span style=\"font-size:12pt;\">Echinococcus parasite is the causative agent</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A 45-year-old male patient underwent a routine USG following which this finding was noted.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/29/picture14.jpg\" alt=\"\" width=\"300\" height=\"181\"></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">What is FALSE regarding the above condition?</span></p>",
      "unique_key": "Q2637760",
      "question_audio": null,
      "question_video": null,
      "map_id": 36503,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. C) PAIR is the treatment of choice in cysto-biliary communication.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>PAIR</strong> (puncture aspiration injection re-aspiration) <strong>is the treatment of choice only in cases where the hydatid cysts have minimal septations</strong> and are <strong>superficial in location</strong>. <strong>Cysto-biliary communication</strong> is a <strong>contraindication for PAIR.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A: Man is the dead-end host, Option D: Echinococcus is causative. Echinococcus granulosus</strong>, the <strong>causative agent of hydatid disease</strong>, has a <strong>life cycle that involves dogs</strong> (definitive host) and <strong>sheep</strong> (intermediate host). <strong>Humans become accidental intermediate hosts by ingesting ova through contaminated food, water, or direct contact</strong> with <strong>dog feces</strong>. Once ingested, the eggs hatch in the intestines, and the larvae can migrate through the portal vein (PV) to various organs, most commonly the liver, where they form hydatid cysts. This is considered a dead-end in the parasite's life cycle because humans are not a part of the natural transmission cycle.</span></p><p style=\"margin-left:48px;text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B:</strong> For conditions like <strong>echinococcus</strong> (hydatid) <strong>cysts</strong>, <strong>FNAC is contraindicated due to the risk of anaphylaxis and spread of infection</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Echinococcus granulosus</strong>, a <strong>parasite with a life cycle</strong> involving <strong>dogs and sheep, causes hydatid disease in humans</strong> who are <strong>accidental hosts.</strong> <strong>PAIR treatment</strong> is <strong>contraindicated in cases of hydatid cysts</strong> with <strong>cysto-biliary communication</strong> due to the risk of <strong>biliary leak and cholangitis.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Ref:</u> Bailey and Love 28<sup>th</sup> Ed. Pg 73-76</strong></span></p>",
      "correct_choice_id": 46992,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11758,
      "choices": [
        {
          "id": 46998,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">According to WHO classification, type 1 hydatid cysts are inactive</span></span></span></p>"
        },
        {
          "id": 46999,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elective clinical presentation is usually in the form of a lump arising from the liver</span></span></span></p>"
        },
        {
          "id": 47000,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anaphylactic shock due to rupture of the hydatid cyst is the emergency presentation </span></span></span></p>"
        },
        {
          "id": 47001,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CT scan is the diagnostic test </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the incorrect statement about hydatid cyst disease in humAns.</span></span></span></p>",
      "unique_key": "Q7226520",
      "question_audio": null,
      "question_video": null,
      "map_id": 36504,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) According to WHO classification, type 1 hydatid cysts are inactive.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This statement is <strong>incorrect</strong>. The <strong>WHO classification categorizes type 1 hydatid cysts</strong> as <strong>active cysts</strong>, usually <strong>larger than 2 cm</strong> and may <strong>contain viable protoscolices</strong>, which are the <strong>infectious forms of the parasite</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Elective clinical presentation is usually in the form of a lump arising from the liver. </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hydatid cysts</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> can indeed <strong>present as a lump or mass in the liver</strong>, which <strong>may or may not be painful</strong>. The presentation can vary from asymptomatic to causing discomfort due to the mass effect.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Anaphylactic shock due to rupture of the hydatid cyst is the emergency presentation. </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rupture of a hydatid cyst</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> can lead to <strong>anaphylactic shock</strong>, which is a <strong>severe allergic reaction</strong> and is considered an emergency presentation. This statement is <strong>correct</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: CT scan is the diagnostic test. </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CT scans are <strong>highly effective in the imaging and diagnosis of hydatid cysts</strong>, providing detailed images that help in identifying the characteristic features of the cysts, such as their outline and internal structure.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>WHO Informal Working Group on Echinococcosis</strong> (WHO-IWGE) proposed a <strong>standardized ultrasound classification based on the status of activity of the cyst</strong>. This is universally accepted, particularly because it helps to decide on the appropriate management. Three groups have been recognized:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Group 1</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Active group &ndash; cysts larger than 2 cm and often fertile.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Group 2</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Transition group &ndash; cysts starting to degenerate and entering a transitional stage because of host resistance or treatment but may contain viable protoscolices.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Group 3</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Inactive group &ndash; degenerated, partially or totally calcified cysts; unlikely to contain viable protoscolices. </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/29/screenshot-2024-03-28-181350.jpg\" style=\"height:510px; width:1000px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ultrasonography and CT scan are the investigations of choice</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. The CT scan shows a smooth space-occupying lesion with several septa.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Radical total or partial pericystectomy with omentoplasty or hepatic segmentectomy</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (especially if the lesion is in a peripheral part of the liver) are <strong>some of the surgical options</strong>. During the operation, scolicidal agents are used, such as hypertonic saline (15&ndash;20%), ethanol (75&ndash;95%) or 5% povidone&ndash;iodine (although some use a 10% solution). This may cause sclerosing cholangitis if biliary radicles are in communication with the cyst wall.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Bailey and Love 28<sup>th</sup> Ed. Pg 73-75</span></strong></span></span></p>",
      "correct_choice_id": 46998,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11759,
      "choices": [
        {
          "id": 47002,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Symptomatic patients present with cough, expectoration, fever, and haemoptysis</span></span></span></p>"
        },
        {
          "id": 47003,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Capitonnage is done for pulmonary hydatids</span></span></span></p>"
        },
        {
          "id": 47004,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Meniscus sign implies impending rupture of cyst</span></span></span></p>"
        },
        {
          "id": 47005,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Medical management is the mainstay</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of these is incorrect about pulmonary hydatid cyst disease?</span></span></span></p>",
      "unique_key": "Q2818806",
      "question_audio": null,
      "question_video": null,
      "map_id": 36505,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Medical management is the mainstay. </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The mainstay of treatment of pulmonary hydatid is surgery. Medical treatments are less successful</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> and considered when <strong>surgery is not possible because of poor general condition</strong> or <strong>diffuse disease affecting both lungs</strong>, or recurrent or ruptured cysts. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Symptomatic patients present with cough, expectoration, fever, and haemoptysis. </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is a <strong>correct statement.</strong> Symptomatic patients with pulmonary hydatid cyst disease can present with these respiratory symptoms as the cysts in the lungs cause irritation and inflammation.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Capitonnage is done for pulmonary hydatids. </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Capitonnage</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is a <strong>surgical technique</strong> used in the <strong>treatment of pulmonary hydatid disease</strong>. It involves the obliteration of the residual cavity after the removal of a hydatid cyst to prevent space problems and secondary infection. This is a correct statement.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Meniscus sign implies impending rupture of cyst. </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>meniscus or crescent sign</strong> refers to the <strong>appearance of air between the pericyst</strong> and the <strong>ectocyst of a hydatid cyst on imaging studies</strong>. It can indicate that the cyst is under tension and may be at risk of rupture. This statement is also correct.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>primary treatment for pulmonary hydatid cyst disease is surgical resection</strong>, with <strong>medical management playing a secondary role</strong>, often when surgery is not possible due to the patient&#39;s condition or when the disease is too diffuse.Top of </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>lung is the second commonest organ affected after the liver</strong>. The size of the cyst can vary from very small to a considerable size. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The right lung and lower lobes are slightly more often involved. The cyst is usually single, although multiple cysts do occur and concomitant hydatid cysts in other organs, such as the liver, are not unknown. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The condition may be silent and found incidentally. Symptomatic patients present with cough, expectoration, fever, chest pain and sometimes haemoptysis.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Silent cysts may present as an emergency because of rupture or an allergic reaction. Uncomplicated cysts present as rounded or oval lesions on chest radiography. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Erosion of the bronchioles results in air being introduced between the pericyst and the laminated membrane and gives a fine radiolucent crescent,<strong> the &lsquo;meniscus&rsquo; or &lsquo;crescent&rsquo; sign. This is often regarded as a sign of impending rupture. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When the cyst ruptures, the crumpled collapsed endocyst floats like a lily on the residual fluid, giving rise to the &lsquo;water-lily&rsquo; sign on CT scan. Rupture into the pleural cavity results in pleural effusion. CT scan defines the pathology in greater detail. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The principle of surgery is to preserve as much viable lung tissue as possible. The exact procedure can vary: cystotomy, capitonnage, pericystectomy, segmentectomy or occasionally pneumonectomy</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Bailey and Love, 28<sup>th</sup> Ed. Pg 76</span></strong></span></span></p>",
      "correct_choice_id": 47005,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11769,
      "choices": [
        {
          "id": 47042,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bilirubin</span></span></span></p>"
        },
        {
          "id": 47043,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Creatinine</span></span></span></p>"
        },
        {
          "id": 47044,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A:G ratio</span></span></span></p>"
        },
        {
          "id": 47045,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">INR</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of these is not a component of MELD score?</span></span></span></p>",
      "unique_key": "Q6583220",
      "question_audio": null,
      "question_video": null,
      "map_id": 36509,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) A: G ratio</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>albumin:globulin</strong> (A:G) <strong>ratio is not a component of the MELD score</strong>. The <strong>A:G ratio is sometimes used in liver function tests</strong> to <strong>assess protein levels in the blood</strong> but is <strong>not part of the MELD calculation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>Model for End-Stage Liver Disease</strong> (MELD) score is a <strong>commonly used prognostic tool</strong> for assessing the <strong>severity of chronic liver disease</strong> and <strong>prioritizing liver transplant candidates.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Bilirubin. </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serum bilirubin levels are a key <strong>component of the MELD score.</strong> They <strong>reflect the liver&#39;s ability to conjugate and excrete bilirubin</strong>, with <strong>higher levels</strong> indicating <strong>more significant liver dysfunction.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Creatinine. </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serum creatinine levels are <strong>included in the MELD score</strong> to <strong>assess renal function</strong>, which can be compromised in patients with end-stage liver disease due to conditions like hepatorenal syndrome.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: INR. </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>International Normalized Ratio</strong> (INR) <strong>measures the time it takes for blood to clot</strong> and is a <strong>critical part of the MELD score.</strong> It reflects the liver&#39;s ability to synthesize clotting factors, with higher values indicating more severe liver disease.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>MELD score</strong>, used to <strong>assess the severity of chronic liver disease</strong> and <strong>prioritize liver transplantation</strong>, includes <strong>serum bilirubin, serum creatinine, and the INR</strong>. The <strong>albumin:globulin ratio is not a component of the MELD score</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A number of parameters are required to accurately assess the degree of liver dysfunction, enable predictions about a patient&rsquo;s ability to tolerate surgical or radiological procedures and assess the prognosis following transplantation.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Two prognostic models commonly used are the Child&ndash;Turcotte&ndash;Pugh (CTP) classification and the Model for End-Stage Liver Disease (MELD) score. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The MELD score was devised to predict the short-term prognosis following Trans jugular intrahepatic portosystemic stent shunt (TIPSS) but has been adopted to prioritize patients on liver transplant waiting lists. In the MELD model survival probability is calculated based on the patient&rsquo;s international normalized ratio (INR), serum bilirubin and creatinine.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MELD scores correlate with operative mortality: 1% increase for each MELD point up to 20 and a further 2% for each point above 20, with rates considerably higher following emergency presentation.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MELD-Na score: Meld + Serum Na levels.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MELD 3.0 score: Age and gender are included.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Bailey 28<sup>th</sup> Ed. Pg 1196</span></strong></span></span></p>",
      "correct_choice_id": 47044,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11776,
      "choices": [
        {
          "id": 47070,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bilobar tumors</span></span></span></p>"
        },
        {
          "id": 47071,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hepatic vein invasion</span></span></span></p>"
        },
        {
          "id": 47072,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Infiltration of CHD</span></span></span></p>"
        },
        {
          "id": 47073,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Portal Vein invasion</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All are contra-indications to onco-surgical resection of HCC (Hepatocellular carcinoma) except:</span></span></p>",
      "unique_key": "Q8114300",
      "question_audio": null,
      "question_video": null,
      "map_id": 36494,
      "difficulty_level": "difficult",
      "subjects_id": [
        12
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Hepatic vein invasion</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hepatic vein invasion</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> was considered a <strong>contraindication due to the risk of inadequate postoperative liver reserve</strong> and the <strong>potential for tumor spread.</strong> However, with <strong>advances in surgical techniques</strong> and <strong>preoperative planning</strong>, <strong>resection may still be possible</strong> in selected cases with <strong>hepatic vein invasion</strong>, making this the exception among the options provided.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Bilobar Tumors. </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bilobar tumors, which are <strong>present in both lobes of the liver</strong>, are generally <strong>considered a contraindication for resection</strong> due to the <strong>difficulty in completely removing all tumor tissue</strong> and the higher risk of postoperative liver failure.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Infiltration of CHD (Common Hepatic Duct). </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Infiltration of the <strong>common hepatic duct</strong> is typically a <strong>contraindication to resection</strong> because it <strong>indicates advanced disease and increases the complexity of the surgery</strong>, which often results in a poor prognosis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: PV Invasion (Portal Vein Invasion). </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Portal vein invasion is also <strong>generally considered a contraindication for resection</strong> due to the <strong>high risk of intrahepatic metastases</strong> and the challenges associated with removing all cancerous tissue.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><strong><u> </u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While the <strong>presence of extrahepatic metastasis</strong>, <strong>multiple or bilobar tumors</strong>, and <strong>invasion of the common hepatic duct</strong> or <strong>portal vein</strong> are <strong>contraindications to the surgical resection of HCC</strong>, <strong>hepatic vein invasion</strong> may not preclude surgery in certain cases, depending on the extent of disease and surgical expertise.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Contra-indications to resection of liver tumors</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul style=\"margin-left:40px\">\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Extra-hepatic metastasis</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Multiple and bilobar tumors</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PV/IVC invasion</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Invasion of CHD</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Multinodular lesions may represent multiple discrete lesions occurring independently against a background of procarcinogenic parenchymal damage or aggressive tumor biology with intrahepatic metastases. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oncological contraindications include extrahepatic metastasis, multiple/bilobar tumors, main bile duct involvement and tumor thrombus in the main portal vein/inferior vena cava</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Bailey 28<sup>th</sup> Ed. Pg 1214</span></strong></span></span></p>",
      "correct_choice_id": 47071,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11779,
      "choices": [
        {
          "id": 47082,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2,3,4</span></span></span></p>"
        },
        {
          "id": 47083,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2,3,4,5,6</span></span></span></p>"
        },
        {
          "id": 47084,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2,3,4,5,8</span></span></span></p>"
        },
        {
          "id": 47085,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1,2,3,4,5</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In extended left hemi-hepatectomy, the liver segments resected are:</span></span></span></p>",
      "unique_key": "Q9306982",
      "question_audio": null,
      "question_video": null,
      "map_id": 36496,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. 2, 3,4,5,8</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Liver resections and segments removed</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Left hemihepatectomy= 2, 3, 4</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Right hemihepatectomy= 5,6,7,8</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Extended right hemihepatectomy/ right trisectionectomy= 4 and 5,6,7,8</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Extended left hemihepatectomy/ left trisectionectomy=2,3,4 and 5,8</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Left lateral hepatectomy= 2 and 3</span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"margin-left:19px; text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/29/picture16.jpg\" style=\"height:335px; width:350px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Bailey 28<sup>th</sup> Ed. Pg 1211 </span></strong></span></span></p>",
      "correct_choice_id": 47084,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11788,
      "choices": [
        {
          "id": 47118,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Milan criteria is applicable for single tumor up to 5 cm or three tumors each less than 3 cm</span></span></span></p>"
        },
        {
          "id": 47119,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A FLR (future liver remnant) of at least 40% normal liver is a pre-requisite for resection</span></span></span></p>"
        },
        {
          "id": 47120,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Colorectal metastasis to liver can be excised</span></span></span></p>"
        },
        {
          "id": 47121,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Percutaneous ablation is used for hepatomas</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of these is incorrect about management of hepatoma?</span></span></span></p>",
      "unique_key": "Q7252401",
      "question_audio": null,
      "question_video": null,
      "map_id": 36500,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) A FLR (Future liver remnant) of at least 40% normal liver is a pre-requisite for resection.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The statement is incorrect because while a larger FLR is generally preferred in patients with cirrhosis, the exact percentage required for safe resection can vary. <strong>The FLR/TELV (Total Estimated Liver Volume) ratio of at least 25% is recommended with a normal liver and 40% in the presence of cirrhosis</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Milan Criteria. </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The Milan criteria are <strong>indeed applicable for liver transplantation in patients with HCC</strong>, specifying that eligible patients should have a single tumor up to 5 cm or up to three tumors, each less than 3 cm. This statement is correct.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Colorectal Metastasis to Liver. </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is <strong>true</strong> that <strong>colorectal metastases to the liver can be excised in certain circumstances.</strong> Liver resection can be part of the treatment for selected patients with metastatic colorectal cancer to the liver, particularly if it is liver-only disease.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Percutaneous Ablation. </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Percutaneous ablation, including <strong>radiofrequency ablation</strong> (RFA) and <strong>other techniques</strong>, is a <strong>treatment option for hepatomas,</strong> especially for patients with small, localized tumors who are not candidates for surgery.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For the <strong>management of hepatoma</strong>, the <strong>Milan criteria guide liver transplantation eligibility, percutaneous ablation</strong> is a <strong>treatment option for localized tumors</strong>, <strong>colorectal metastasis</strong> to the <strong>liver may be resected in selected patients</strong>, and the requirement for future liver remnant volume must be individualized, particularly considering the presence of underlying liver disease.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">There is no clear consensus about the volume required for adequate postresection liver function but an FLR/TELV ratio of <strong>at least 25% is recommended with a normal liver and 40% in the presence of cirrhosis.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ablation techniques now include RFA, microwave ablation, cryoablation, laser ablation, irreversible electroporation (IRE) and alcohol injection, all of which can be performed percutaneously, laparoscopically or at open surgery.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Patients with small-volume resectable lesions who are not sufficiently fit to undergo liver resection should be considered for ablation, as should those with liver metastases were predicted FLR precludes resection.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Liver transplantation that definitively treats the tumour and underlying cirrhosis represents an attractive option. Transplantation for HCC, first described by Mazzaferro in 1996 for patients with tumours &le;5&nbsp;cm or up to three nodules &le;3&nbsp;cm, achieved 4-year overall survivals of 75% and recurrence-free survivals of 83%. These inclusion criteria were adopted as the<strong> Milan criteria</strong>, with angioinvasion and extrahepatic involvement as additional exclusion criteria, and are now universally accepted.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Up to 70% of patients with CRC develop synchronous (15&ndash;25%) or metachronous (20&ndash;45%) liver metastases. Liver resection in selected patients with liver-only metastatic disease demonstrated 5-year survivals of 50%, so the potential benefits were recognised. Despite recent advances in chemotherapeutic agents, resection remains the only potentially curative option, but only 20% of patients will be candidates at presentation.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Bailey 28<sup>th</sup> Ed. Pg 1212, 1216.</span></span></strong></p>",
      "correct_choice_id": 47119,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}